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Congenital heart disease (CHD) is common and accounts for 
more deaths than any other type of congenital malformation. The 
incidence of significant CHD is said to be 8 - 9 per 1 000 live births 
and that of critical congenital heart disease (CCHD), which leads to 
death or needs surgical intervention before 28 days, approximately 
2 - 3 per 1 000.[1,2] These incidences are constant worldwide, across 
geographical and ethnic backgrounds and in spite of variations in 
socioeconomic conditions,[3] but are thought to be underestimated in 
countries where antenatal booking is delayed or prenatal ultrasound 
screening not uniformly practised.[4] Early diagnosis currently relies 
on antenatal fetal anomaly screening and neonatal examination. In 
South Africa (SA), the vast majority of congenital cardiac lesions are 
not diagnosed before birth owing to limited antenatal screening for 
CHD.
Cardiac services have improved, and most newborns with CCHD 
can be diagnosed with echocardiography, stabilised with prosta-
glandin and treated with surgery or trans-catheter intervention. [5] 
Without an early diagnosis and appropriate treatment, half of those 
born with significant CHD will die in infancy or early childhood, a 
third of them within the first month of life.[4,6]
Newborn pulse oximetry (POx) is the first appropriately simple 
method for universal screening for CHD,[7] the earliest reports 
having been published in 1995. The rationale is that most CCHD 
results in a degree of hypoxaemia that would not necessarily produce 
visible cyanosis and would therefore not be clinically detectable. 
There is significant evidence that early detection of CCHD through 
POx monitoring is an effective strategy for reducing morbidity and 
mortality rates in young children.[8-11] In 2009, the American Heart 
Association (AHA) and the American Academy of Pediatrics (AAP) 
released a scientific statement concluding that ‘methods to improve 
the early detection of CCHD appear warranted’ and called for larger 
population-based studies on implementation.[5]
In 2011, the AAP and the Secretary for Health and Human 
Services recommended the addition of POx screening to routine 
newborn screening to detect CCHD in the USA. Most US states have 
adopted POx screening into routine newborn screening.[12] Many 
European multicentre studies have been performed, several European 
countries screen routinely, and the UK is trialling implementation 
on a large scale.[8-10,13] In a large cost-effectiveness analysis, Ewer 
et al.[14] concluded that ‘... pulse oximetry is a simple, safe, feasible 
test that is acceptable to parents and staff and adds value to existing 
screening. It is likely to identify cases of CCHDs that would otherwise 
go undetected. It is also likely to be cost-effective given current 
acceptable thresholds. The detection of other pathologies, such 
as non-critical CHD and respiratory and infective illnesses, is an 
additional advantage …’[14]
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Background. Early detection of critical congenital heart disease (CCHD) through newborn pulse oximetry (POx) screening is an effective 
strategy for reducing paediatric morbidity and mortality rates and has been adopted by much of the developed world.
Objectives. To document the feasibility of implementing pre-discharge POx screening in well babies born at Mowbray Maternity Hospital, 
a busy government hospital in Cape Town, South Africa. Parent and staff acceptance was assessed.
Methods. We conducted a prospective study of predischarge POx screening in one postnatal ward, following informed parental consent.
Results. During the 4-month study period, 1 017 of 2 256 babies discharged (45.1%) were offered POx screening and 1 001 were screened; 94.0% 
of tests took <3 minutes to perform, 4.3% 3 - 5 minutes and 1.7% >5 minutes. Eighteen patients needed second screens and three required third 
screens. Only 3.1% protocol errors were made, all without consequence. The vast majority (91.6%) of nursing staff reported insufficient time to 
perform the study screening in addition to their daily tasks, but ~75% felt that with a full nursing staff complement and if done routinely (not part 
of a study), pre-discharge POx screening could be successfully instituted at our facility. Over 98% of the mothers had positive comments. Two 
babies failed screening and required echocardiograms; one was diagnosed with CCHD and the other with neonatal sepsis. The sensitivity and 
specificity were 50% (95% confidence interval (CI) 1.3 - 98.7%) and 99.9% (95% CI 99.4 - 100%), respectively, with a percentage correct of 99.8%.
Conclusions. POx screening was supported and accepted by staff and parents. If there are no nursing staff shortages and if it is done 
routinely before discharge, not as part of a study, we conclude that POx screening could be implemented successfully without excessive false 
positives or errors, or any additional burden to cardiology services.
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Objectives
The primary objective of this study was 
to test and document the implementation 
feasibility of POx screening at Mowbray 
Maternity Hospital (MMH), a busy level 
2 maternity hospital in the Western Cape 
Province, SA. The majority of infants in 
SA are born in similar or lower-level care 
settings. We also assessed nursing and 
parental acceptance. Our secondary aims 
were to determine the number and spectrum 
of CCHD and other significant illnesses 
identified and to report sensitivity and 
speci ficity of POx screening using Nellcor 
Oximetry technology (currently used in 
most Western Cape state facilities).
Methods
This was a prospective pilot study of imple-
mentation of predischarge newborn POx 
screening at sea level, following informed 
parental consent, in our busiest MMH 
postnatal ward. The study period was 
from 19 May to 19 September 2014. Ethics 
approval was granted from the Human 
Research Ethics Committee, Faculty of 
Health Sciences, University of Cape Town 
(HREC Ref. 661/2013) and from the 
Mowbray Maternity Hospital Research 
Committee.
Setting
MMH is a secondary-level maternity hospi-
tal serving several local midwife obstetric 
units (MOUs) as well as the surrounding 
area. Patients are referred from the Mitchell’s 
Plain, Gugulethu, Retreat and Hanover Park 
MOUs and False Bay Hospital, therefore 
representing the bulk of medium-risk preg-
nancies in our region. Of the ~38 000 births 
in the Metropole West region of the Western 
Cape each year, ~11 400 (about one-third) 
are facilitated at MMH, which during 2014 
had 950 deliveries a month on average.
One postnatal ward, B ward, was selected 
because it is MMH’s busiest postnatal ward, 
which at the time of the study received ~40% 
mothers after normal vaginal deliveries, who 
may be discharged after 6 hours, and ~60% 
after caesarean section deliveries, discharged 
at 72 hours or later. B ward generally 
received the ‘sicker’ mothers or those with 
more complications, and discharged an aver-
age of 570 babies per month, 19 per day. 
During our study period, with general staff 
shortages, B ward had an average of 5 staff 
members per 12-hour shift (3 sisters, 1 staff 
nurse and 1 enrolled nursing assistant).
Training and consent
All Mowbray staff shifts received POx edu-
cation and practical training. As per protocol 
(Fig. 1), all saturations <90% were to be 
interpreted as an ‘immediate fail’ and the 
paediatric medical officer was to be called to 
review the baby. Saturations of >90 - <95%, 
as well as arm-leg saturation differences of 
≥4%, required a second screen.
The mothers admitted to B ward received 
a POx pamphlet in their own language 
(English/Afrikaans/Xhosa). The staff mem-
ber allocated to identify and process the 
discharges for that day did room-to-room 
parent education, explaining POx screening 
and the study. If a mother verbally consented, 
the screening was done at the bedside with 
ample opportunity for the mother to ask 
questions. A detailed study register was 
kept, detailing the baby’s screening age, the 
saturations measured, how long it took, and 
comments. After screening, the mothers 
were asked to fill in a questionnaire. Nurses 
were asked to complete an anonymous 
questionnaire and to comment on the 
screening procedure.
Inclusion and exclusion criteria
All neonates >6 hours old with no clinical 
signs of cardiovascular disease were eligible 
for study enrolment. ‘Unwell’ infants, those 
<6  hours old, or those born to mothers 
<14 years of age or unable to give informed 
verbal consent (due to illness, illiteracy or 
language barriers) were not eligible. All 
infants with a prenatal diagnosis of CHD or 
any signs of CHD, including a heart murmur 
(≥3/6) or significant dysmorphic features, 
were excluded.
All babies screened had a sticker placed 
on their Road To Health Card noting that 
POx screening had been performed, with 
a request to contact the investigators in the 
event of a subsequent diagnosis of CHD. 
Local death registers, the Perinatal Problem 
Identification Programme database and 
the Red Cross War Memorial Children’s 
Hospital cardiology database were checked 
for any false negatives up to 9 months after 
the end of the study.
Statistical analysis
Data were captured in a detailed study regis-
ter, and transferred to an Excel spreadsheet 
(2010, Microsoft, USA) and subsequently 
to Stata 11.2 (StataCorp, USA) for analysis. 
The 95% confidence intervals (CIs) were 
Well term or near-term ward baby, ≥6 hours old,
shortly before discharge
(Any unwell infant, preterm <36 weeks, with clinical signs or a prenatal diagnosis of CHD or signicant
dysmorphic features should be referred to the paediatrician)
Briey explain to the parent the potential POx screening has to detect ‘silent’ critical CHD before discharge,
allowing early treatment and saving lives, emphasising this is only a ‘screening’ test that does not exclude
CHD, but lowers the probability. Describe the test to the parent and explain that it is part of a study and not compulsory.
Refer to the information sheet and obtain verbal consent. Help the parent to warm and calm the infant.
1. Pulse oximetry of right hand and any foot 
90 - <95% in right hand or foot 
 OR
≥4% dierence between 
right hand and foot
FAIL <90% in right
hand OR foot
2. Repeat pulse oximetry screen in 1 - 2 hours
3. Repeat pulse oximetry screen in 1 - 2 hours
•  Normal newborn care
•  Complete ward register 
•  Questionnaire from mother
•  Sticker into Road To Health Card
•  Clinical assessment by paediatrician
•  Parental counselling
Clinically well, sats >90% Any clinical or haemodynamic concerns
Admit to nursery, discuss with senior, and refer for
echocardiography as soon as clinically appropriate
Keep in ward with mother,
 refer for echocardiography as soon as practical
PASS
PASS
PASS
FAIL
FAIL
IMMEDIATE FAIL
≥95% in right hand and foot AND
≤3% dierence between
 right hand and foot
PASS
Fig. 1. POPSICLe study protocol. (Adapted from the proposed protocol in Kemper et al.,[12] similar to 
Ewer et al.’s[14] Health Technology Assessment protocol and with advice from Anne de-Wahl Granelli.) 
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calculated using the ‘cii’ command in Stata. 
Continuous variables were summarised 
as means (standard deviation) or medians 
(interquartile range (IQR)), and categorical 
data using frequency and percentages. 
We also computed the diagnostic odds 
ratio (OR), which is a single measure of 
effectiveness of a diagnostic test that is 
independent of prevalence. A diagnostic OR 
of >1 is indicative of a discriminatory test, 
whereas a diagnostic OR of >400 indicates 
an acceptable effect size.[15]
Results
Nursing staff were able to approach 1 017 
mothers of the 2 256 babies discharged 
during the study period. We were therefore 
able to offer predischarge saturation screen-
ing to 45.1% of all B-ward infant discharges. 
Of these mothers, 1 001 (98.4%) consented 
to be included.
A total of 1 001 babies were screened, at 
a median age of 60 hours (IQR 36 - 77). 
Thirty (3.0%) were >5 days old and 104 
(10.4%) were <24 hours old. The latest screen 
was at 170 hours of age and the earliest at 7 
hours. There was no significant difference 
between saturation values of babies tested 
at <24 hours (mean 97.%), ≥24 - 120 hours 
(97.8%) or >120 hours (98.1%).
Of the 1 001 babies screened, only 18 
(1.8%) needed a second screen. Four of the 
second screens should have been ‘immediate 
fails’ because one saturation was <90% (86 - 
88%), but all passed on the second screen. 
These were counted as ‘protocol errors’. Three 
third screens (0.3%) were needed, 2 owing to 
technical issues (probe needed replacement), 
while 1 baby was appropriately admitted to 
the neonatal intensive care unit (NICU) with 
pneumonia/septicaemia (Table 1).
The ward register comments showed that 
97.8% of the tests were perceived as ‘easy’ 
to perform. These babies were described as 
calm, asleep or breastfeeding. Five babies 
were noted to be crying, but the test was still 
easy to perform. Twenty-four tests (2.3%) 
were difficult to perform: 16 babies were 
restless or crying, there was a technical 
issue in 7 cases (difficulty with probe place-
ment, probe or machine malfunction), and 
1  case was assessed as difficult because the 
baby failed all three screens and needed 
admission.
In total, 1 022 screens were done: 961 
(94.0%) took <3 minutes to perform, 
while 44 (4.3%) took between 3 and 5 
minutes. Of these, 11 were failed first or 
second screening tests. Seventeen tests 
(1.7%) took >5 minutes to perform: 3 
took long because the baby was crying or 
restless, in 5 there were technical problems 
with probe or machine malfunction, and 
1 infant failed all three tests and was 
admitted (Table 2).
Thirty-one protocol errors (3.1%) were 
made: 4 were a second screen that should 
have been an immediate fail, and all the 
infants passed on the second screen. Seven-
teen errors were recorded because saturation 
measurements of 90 - 94% were accepted as a 
pass, and 10 because a difference of ≥4% was 
accepted as a pass where arm-leg saturations 
were 96 - 100% (n=4), 95 - 99% (n=1), 95 - 
100% (n=1), 100 - 95% (n=3) and 99 - 95% 
(n=1). All of the error cases were followed up 
and all the babies were well, except for one 
twin who died aged 3 months in the Congo 
with ‘coughing’.
Only two patients (0.2%) failed the 
screen ing, were admitted to the NICU and 
had an echocardiogram. The first was an 
imme diate fail on the first screen, and the 
echocardiogram revealed a trans position of 
the great arteries (TGA). Oral prostaglandin 
was started and she was transferred to a 
cardiac centre in good condition, where she 
had a successful arterial switch operation the 
following day with no complications. The 
other patient failed three screens and was 
admitted to the NICU with respiratory distress 
and elevated septic markers. He required 
3 days of nasal continuous positive airway 
pressure ventilation (nCPAP) and 7 days of 
intravenous antibiotics. The echocardiogram 
was normal. Feedback from the local tertiary 
paediatric cardiology service revealed that 
one patient with a coarctation of the aorta 
was missed (false-negative rate 0.09%) by 
our screening; the patient presented to the 
Red Cross War Memorial Children’s Hospital 
emergency room in an unstable condition at 
the age of 6.5 weeks (Fig. 2).
In this pilot study, the sensitivity was 
50% (95% CI 1.3 - 98.7) and the specificity 
99.9% (95% CI 99.4 - 100), with a test uti-
lity (%  correct) of 99.8%. The calculated 
diagnostic OR was 999.
During the study period, another 
three  babies were clinically diagnosed with 
signi ficant cardiac lesions (tetralogy of 
Fallot, atrio ventricular septal defect (AVSD), 
double-outlet right ventricle with ventricular 
septal defect and pulmonary stenosis) from 
the same ward, which excluded them from 
screen ing. The incidence of CCHD in 
B ward over the study period was therefore 
4  per 1 000, the AVSD being a significant 
cardiac lesion but not critical. The one error 
case in which a twin died of ‘coughing’ in the 
Congo at the age of 3 months may also have 
been severe CHD.
Table 1. POPSICLe need for second and third screens, or echocardiography
2nd screen needed 3rd screen needed Echocardiograms 
Patients, n 18 3 2
Reason/nurse’s comment 15 passed on 2nd screen 2 technical issues (new probe needed) 1 TGA (immediate fail)
3 went on to 3rd screen 1 appropriate, failed 3 screens, assessed by paediatrician 
and admitted to NICU
1 sepsis/congenital pneumonia
Table 2. POPSICLe screening time assessment
Time screen took (min)
Total <3 3 - 5 >5 
Screens, n 961 44 17 1 022
Reason/nurse’s 
comment
Calm/feeding/
sleeping/easy
7 crying/restless 3 crying a lot
4 technical issues 5 technical issues
33 easy/calm 6 easy/calm
1 immediate fail, 
admitted
3 calm but difficult  
(1 failed 3 screens, admitted)
11 failed first/second 
screens
10 failed first/second  
screens
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Feedback from nurses
All the nurses involved were satisfied that 
the purpose and aims of the study were 
easy to understand and the study protocol 
was easy to follow. All but one nurse felt 
confident and able to explain the purpose 
and limitations of screening adequately after 
the training sessions. Three nurses said that 
they would have preferred a paediatrician 
to explain the process to the parents. Only 
one nurse found the screening difficult 
to perform. Most (91.6%) of the nursing 
feed back indicated that the nurses did not 
have enough time to perform the screening 
as well as complete their routine required 
tasks. One nurse commented specifically 
that the study screening time was increased 
owing to the paperwork required for the 
study, which would be less if screening was 
routine. Half of the nurses felt that it would 
be possible to introduce screening into 
everyday routine at MMH. However, 25% 
felt it would only be possible if adequate 
nursing staff were available. Another 25% 
felt it would not be possible with the current 
staffing allocation.
Feedback from parents
We received feedback from 726 patients, 
16 who refused screening and 710 who 
consented. Of those who refused, 4 stated 
they were too anxious about possible 
outcomes of the screening. One mother 
refused because she felt overwhelmed by 
‘the numerous routine procedures that she 
and her baby had been subjected to’. One 
mother was uncomfortable with the idea of 
being involved in a study, and another felt 
confident that her child was healthy and did 
not feel that further tests were necessary. 
The remaining mothers did not give reasons 
for their refusal to participate. Two nurses 
observed that mothers who refused testing 
did so because they were eager to leave the 
hospital and were worried that screening 
might have meant staying longer.
Of the 710 screened patients who filled 
in the parent’s question naire, 700 (98.6%) 
stated that the test was adequately explained, 
the time taken acceptable, and the screening 
as a whole acceptable and beneficial to 
their child’s and other children’s health. 
Interestingly, two of these patients felt that 
the screening was too quick and that more 
time should have been taken. Forty mothers 
commented specifically that screening 
was worthwhile and that they appreciated 
their babies being screened. Four mothers 
commented that screening should be offered 
to all babies. Eight mothers (1.1%) felt the 
time taken was too long. Two mothers (0.3%) 
said that, although they had consented, 
screening was of no benefit to their child. In 
summary, 98.6% of mothers who consented 
to their babies receiving screening felt that 
the test was acceptable and beneficial.
Discussion
Our study documents the practical feasibility 
of newborn POx screen ing for CCHD in a 
large public sector maternity hospital in SA, 
plus provider and parental attitudes to it. We 
demonstrated acceptance from parents and 
staff, and an appropriate sensitivity and a 
high specificity for POx screening at sea level. 
Our pilot study of 1 001 patients showed a 
sensitivity of 50% and specificity of 99.9%, 
and one false-positive case with neonatal 
sepsis. This compares well with Thang-
aratinam et al.’s[11] systematic review and 
meta-analysis of 229 421 babies screened, 
which showed an overall sensitivity of 76.5%, 
specificity of 99.9% and false-positive ratio 
of 0.14%. Our lower sensitivity reflects our 
small study number and only two patients 
failing the screen, one with a true CCHD and 
one with neonatal sepsis. This low incidence 
probably also reflects our good clinical pick-
up of CHD, these cases being excluded 
from the study. Our hospital is viewed as 
one of the better-resourced secondary-level 
hospitals in the country, where a doctor 
reviews all infants daily. However, in terms 
of nursing staff, severe staffing resource 
challenges during our study period resulted 
in our only offering screening to 45.1% 
of babies discharged from the study ward. 
Yet the diagnostic ability of the test was 
significant, with high specificity, diagnostic 
odds and percentage correct.
We postulate that routine screening, not part 
of a study, would translate into less nursing 
time spent explaining, consenting and 
completing paperwork, which may result 
in a higher percentage screened. We did not 
employ any additional staff, so the nurse 
doing the screening was required to perform 
all the necessary explanations, consent and 
paperwork required by the study. During our 
study period, we discovered that an average 
of five nursing staff per shift had to discharge 
an average of 19 babies and 20 mothers 
per day, in addition to their routine care 
of inpatients in a 46-bed ward with a bed 
occupancy rate of 98 - 100%. This represents 
an enormous amount of work. We suggest 
that with a full complement of nurses or one 
extra nurse per shift, routine POx screening 
could be implemented at MMH with much 
better coverage.
Despite severe staff shortages, the ever-
increasing patient-to-staff ratio and increas-
ing client expectations, our nursing staff 
viewed POx screening favourably and were 
eager to see it implemented routinely. Our 
study also confirmed parental acceptance. 
Most of the mothers from whom feedback 
was obtained felt that routine screening 
should be standard practice.
Many studies have documented the 
benefits and feasibility of POx screening in 
developed countries.[8-10,13] SA and lesser-
resourced countries, however, face many 
barriers to implementation of routine POx 
screening. Most of these barriers stem from 
an underfunded health service caring for an 
ever-increasing patient load. This translates 
to fewer staff (medical and nursing) hours 
2 256 postnatal mother and infant discharges from B ward, 19 May - 19 September 2014  
(Note: B ward had an additional 148 maternal discharges during the study period)
1 017 mothers approached 1 220 mothers not approached Infants not eligible for enrolment
2 CCHDs identied
clinically
Language
barrier
Maternal
age <14 years
1 001 consented, enrolled, screened 16 refused
999 passed 2 failed (needed echocardiograms)
1 missed CCHD 
(1 false negative)
TGA Congenital pneumonia/
septicaemia
Coarctation, presented
at 6.5 weeks
Prostaglandin started, transferred,
successful arterial switch
Required nCPAP 3 days,
antibiotics 7 days
Fig. 2. POPSICLe study findings.
RESEARCH
821       August 2016, Vol. 106, No. 8
and less equipment available than is desirable for the clinical service 
required.
Almost all birthing facilities in the Western Cape are in the process 
of obtaining saturation monitors, since these are now deemed 
essential in neonatal resuscitation and neonatal care. POx training 
for all staff will therefore be essential and POx monitors will become 
available everywhere. POx did prove simple enough to implement in 
our setting. With regard to cost, probes are relatively cheap and in our 
study practically proved to be re-usable multiple times. 
Our study’s two echocardiograms per 1 001 babies debunk the 
argument that POx screening will add to the burden of an already 
overloaded cardiac service. Our local cardiac service welcomes early 
diagnosis of CHD, which decreases the mortality, morbidity and cost 
associated with late referrals.
Study limitations
Firstly, the study was done only at one institution. Staffing and 
equipment availability may be very different at other birthing 
facilities. However, being one of the busiest birthing facilities and 
the site of nearly one-third of the births in the Western Metropole, 
MMH may still be a good representation of our area in the Western 
Cape, and with our nursing staff shortages experienced, we probably 
compare well with most Western Cape hospitals. Secondly, our 
study was a pilot done in only one postnatal ward, our busiest. 
Other ‘quieter’ postnatal wards may have had a higher screening 
rate. Thirdly, since this was an implementation feasibility study with 
no control group and no physical follow-up, interpretation of our 
specific case findings is of limited value. Potential false negatives 
may not have been fed back to the investigators, undermining the 
accuracy of this screening, although all efforts were made to trace any 
‘missed’ cases and POx screening accuracy has already been proven 
internationally. Lastly, interpretation of staff or parents’ comments 
may be subjective, but the written anonymous questionnaires showed 
acceptance and an overwhelmingly favourable response. 
Implications for practice
‘Implementation feasibility’ means a high success rate of screening 
along with sufficiently low barriers and resource drain. The screening 
success rate attained has been discussed. In our study the anticipated 
barriers of increased cardiology service workload, cardiac care 
costs, high equipment expense and lack of acceptance by parents 
and nursing staff were not encountered. Our study also showed that 
the age at which screening is done (as long as it is >6 hours after 
birth) is not relevant when tested at sea level. This is in keeping with 
the findings of most large multicentre studies and reconfirms the 
practical potential for all newborns to have predischarge screening 
even when discharged at 6 hours after birth. The only significant 
barrier was a shortage of nursing staff time, which unfortunately is 
a reality in the majority of health facilities in SA. We postulate that 
routine predischarge screening, not part of a study and translating to 
less nursing time per screen, will lead to a higher screen rate. Also, 
the ongoing controversy over whether both pre- and postductal 
screening is significantly superior to a single postductal screen[16] may 
mean that a single foot saturation screen before discharge is the more 
practical solution in resource-limited settings.
Conclusion
POx screening was accepted and supported by both staff and 
parents. We believe that if not part of a study, but done as a routine 
and with adequate nursing staff, it could be implemented successfully 
with a high screen rate and without excessive false positives or 
errors. Our study confirms that POx screening does not significantly 
increase the paediatric cardiology service workload. Earlier diagnosis 
and management should reduce morbidity and ultimately reduce cost 
and workload.
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